View in EDS HTML Full Text PDF Full Text

TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis.

Saved in:
Bibliographic Details
Title: TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis.
Authors: Medford AJ; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Oshry L; Boston Medical Center, Boston, MA, USA.; Boston University School of Medicine, Boston, MA, USA., Boyraz B; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Kiedrowski L; Guardant Health, Inc., Redwood City, CA, USA., Menshikova S; BostonGene Corporation, Boston, MA, USA., Butusova A; BostonGene Corporation, Boston, MA, USA., Dai CS; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Gogakos T; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Keenan JC; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Occhiogrosso RH; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Ryan P; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Lennerz JK; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Spring LM; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Moy B; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ellisen LW; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Bardia A; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Jan 30; Vol. 15, pp. 17588359231152844. Date of Electronic Publication: 2023 Jan 30 (Print Publication: 2023).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36743521
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Medford+AJ%22">Medford AJ</searchLink>; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA.; Dana Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Oshry+L%22">Oshry L</searchLink>; Boston Medical Center, Boston, MA, USA.; Boston University School of Medicine, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Boyraz+B%22">Boyraz B</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kiedrowski+L%22">Kiedrowski L</searchLink>; Guardant Health, Inc., Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Menshikova+S%22">Menshikova S</searchLink>; BostonGene Corporation, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Butusova+A%22">Butusova A</searchLink>; BostonGene Corporation, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dai+CS%22">Dai CS</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gogakos+T%22">Gogakos T</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Keenan+JC%22">Keenan JC</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Occhiogrosso+RH%22">Occhiogrosso RH</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ryan+P%22">Ryan P</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lennerz+JK%22">Lennerz JK</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Spring+LM%22">Spring LM</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moy+B%22">Moy B</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ellisen+LW%22">Ellisen LW</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bardia+A%22">Bardia A</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101510808%22">Therapeutic advances in medical oncology</searchLink> [Ther Adv Med Oncol] 2023 Jan 30; Vol. 15, pp. 17588359231152844. <i>Date of Electronic Publication: </i>2023 Jan 30 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101510808 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1758-8340 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217588340%22">17588340 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Med Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36743521
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/17588359231152844
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17588359231152844
    Titles:
      – TitleFull: TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Medford AJ
      – PersonEntity:
          Name:
            NameFull: Oshry L
      – PersonEntity:
          Name:
            NameFull: Boyraz B
      – PersonEntity:
          Name:
            NameFull: Kiedrowski L
      – PersonEntity:
          Name:
            NameFull: Menshikova S
      – PersonEntity:
          Name:
            NameFull: Butusova A
      – PersonEntity:
          Name:
            NameFull: Dai CS
      – PersonEntity:
          Name:
            NameFull: Gogakos T
      – PersonEntity:
          Name:
            NameFull: Keenan JC
      – PersonEntity:
          Name:
            NameFull: Occhiogrosso RH
      – PersonEntity:
          Name:
            NameFull: Ryan P
      – PersonEntity:
          Name:
            NameFull: Lennerz JK
      – PersonEntity:
          Name:
            NameFull: Spring LM
      – PersonEntity:
          Name:
            NameFull: Moy B
      – PersonEntity:
          Name:
            NameFull: Ellisen LW
      – PersonEntity:
          Name:
            NameFull: Bardia A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 01
              Text: 2023 Jan 30
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 1758-8340
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Therapeutic advances in medical oncology
              Type: main
ResultId 1